Imagen 1 de 1
Imagen 1 de 1
Race in a Bottle, Hardcover by Kahn, Jonathan, Like New Used, Free shipping i...
USD108,50
Aproximadamente97,30 EUR
Estado:
Como nuevo
Libro en perfecto estado y poco leído. La tapa no tiene desperfectos y si procede, con sobrecubierta para las tapas duras. Incluye todas las páginas sin arrugas ni roturas. El texto no está subrayado ni resaltado de forma alguna, y no hay anotaciones en los márgenes. Puede presentar marcas de identificación mínimas en la contraportada o las guardas. Muy poco usado. Consulta el anuncio del vendedor para obtener más información y la descripción de cualquier posible imperfección.
2 disponibles
Envío:
Gratis Economy Shipping.
Ubicado en: Jessup, Maryland, Estados Unidos
Entrega:
Entrega prevista entre el mié. 9 oct. y el mié. 16 oct. a 43230
Devoluciones:
14 días para devoluciones. El comprador paga el envío de la devolución.
Pagos:
Compra con confianza
El vendedor asume toda la responsabilidad de este anuncio.
N.º de artículo de eBay:386850940191
Última actualización el 17 sep 2024 17:35:24 H.EspVer todas las actualizacionesVer todas las actualizaciones
Características del artículo
- Estado
- Book Title
- Race in a Bottle
- ISBN
- 9780231162982
- Subject Area
- Political Science, Social Science, Medical
- Publication Name
- Race in a Bottle : the Story of Bidil and Racialized Medicine in a Post-Genomic Age
- Publisher
- Columbia University Press
- Item Length
- 0.9 in
- Subject
- Ethics, Chemotherapy, Public Health, Public Policy / General, Ethnic Studies / African American Studies
- Publication Year
- 2012
- Type
- Textbook
- Format
- Hardcover
- Language
- English
- Item Height
- 0.1 in
- Item Weight
- 20.2 Oz
- Item Width
- 0.6 in
- Number of Pages
- 328 Pages
Acerca de este producto
Product Identifiers
Publisher
Columbia University Press
ISBN-10
0231162987
ISBN-13
9780231162982
eBay Product ID (ePID)
117142722
Product Key Features
Number of Pages
328 Pages
Publication Name
Race in a Bottle : the Story of Bidil and Racialized Medicine in a Post-Genomic Age
Language
English
Subject
Ethics, Chemotherapy, Public Health, Public Policy / General, Ethnic Studies / African American Studies
Publication Year
2012
Type
Textbook
Subject Area
Political Science, Social Science, Medical
Format
Hardcover
Dimensions
Item Height
0.1 in
Item Weight
20.2 Oz
Item Length
0.9 in
Item Width
0.6 in
Additional Product Features
Intended Audience
Scholarly & Professional
LCCN
2012-023167
Reviews
Kahn's book should be required reading. At a time when the ties between scientific researchers and the pharmaceutical industry are becoming ever more entangled, Race in a Bottle provides valuable insights into the consequences of these connections for health and health care - and, importantly, for what passes as knowledge., [Jonathan Kahn's] rich portrayal of the changing meaning and uses of race in the wake of genomics makes this book a 'must read' and 'must assign' for all sociologists of race and ethnicity., [Jonathan Kahn's] rich portrayal of the changing meaning and uses of race in the wake of genomics makes this book a "must read" and "must assign" for all sociologists of race and ethnicity., Jonathan Kahn's approach offers an airtight analysis of the commoditization of race in pharmaceutical development, and Race in a Bottle should be of interest and deep concern to numerous audiences., Kahn's approach offers an airtight analysis of the commoditization of race in pharmaceutical development, and Race in a Bottle should be of interest and deep concern to numerous audiences., Jonathan Kahn is the undisputed Hercules Poirot of biomedicine. His unraveling of the nonsense, non-science, and complicated illogic that allowed the vasodilator BiDil to be approved by the FDA exclusively for 'black' patients is as compelling a read as any good mystery. This riveting book details what happens to scientific method when profit motive drives the marketing of a drug to the extent that its curative properties are touted as race-specific -- even when they're not. Genetic variation in humans has no correlation to the shifting historical meanings of race, yet pharmaceutical companies continue to force the square peg of social category into the round hole of scientific fact. Race in a Bottle is a brilliant deconstruction of the kinds of thought processes that make for bad policy, bad medicine, and ultimately endanger our health as a species., Race in a Bottle is lucid and energetic, with fascinating and little-known evidence about clinical trials, the federal regulatory and patent systems, and the history of racial classification.... Kahn offers a heartfelt and persuasive case against allowing race to be reduced to biology., Jonathan Kahn has produced a major and unique contribution, giving readers a 'big picture' understanding of this vital issue by integrating empirically grounded analysis of real controversies into a detailed conceptual roadmap. This is a substantial piece of scholarship and will be of interest to anyone concerned with the escalating, even geometrically expanding use of the concept of race in science and medicine., Kahn expertly weaves together the legal and ethical ramifications of continuing to pursue racialized drugs.... No background in health sciences or genetics is necessary to understand this work., [Kahn] skillfully uses the story of the drug BiDil... as the backdrop for examining the expanding role of race in medical genomics, even when the same science has called the existence of race into serious doubt., Jonathan Kahn brilliantly exposes the stunning truth behind new race-based medicines: they are driven by market incentives, not scientific evidence. Based on meticulous research and astute analysis, Kahn constructs a gripping, devastating portrait of profit motivating the use of race in genetic research and pharmaceuticals. Race in a Bottle is absolutely essential for understanding why the myth of biological race has reemerged in genomic science and biotechnology and how it is distorting research, damaging pubic health, and undermining justice in our supposedly post-racial society., [ Race in a Bottle ] tackle[s] one of the most important concerns pertaining to race facing our society today.... Must-read material.New Scientist, [ Race in a Bottle ] tackle[s] one of the most important concerns pertaining to race facing our society today.... Must-read material., Jonathan Kahn is the undisputed Hercules Poirot of biomedicine. His unraveling of the nonsense, non-science, and complicated illogic that allowed the vasodilator BiDil to be approved by the FDA exclusively for 'black' patients is as compelling a read as any good mystery. This riveting book details what happens to scientific method when profit motive drives the marketing of a drug to the extent that its curative properties are touted as race-specific-even when they're not. Genetic variation in humans has no correlation to the shifting historical meanings of race, yet pharmaceutical companies continue to force the square peg of social category into the round hole of scientific fact. Race in a Bottle is a brilliant deconstruction of the kinds of thought processes that make for bad policy, bad medicine, and ultimately endanger our health as a species., Jonathan Kahn is the undisputed Hercules Poirot of biomedicine. His unraveling of the nonsense, non-science, and complicated illogic that allowed the vasodilator BiDil to be approved by the FDA exclusively for 'black' patients is as compelling a read as any good mystery. This riveting book details what happens to scientific method when profit motive drives the marketing of a drug to the extent that its curative properties are touted as race-specific--even when they're not. Genetic variation in humans has no correlation to the shifting historical meanings of race, yet pharmaceutical companies continue to force the square peg of social category into the round hole of scientific fact. Race in a Bottle is a brilliant deconstruction of the kinds of thought processes that make for bad policy, bad medicine, and ultimately endanger our health as a species., A powerful saga packed with engrossing twists and turns of plot and filled with food for thought and debate on the politics and health implications of racial perception., Mr. Kahn deserves credit for teasing out all the daunting complexities behind these events, including the details of genetic analysis, the perils of racial determinations, and the minutiae of patent law., Mr. Kahn deserves credit for teasing out all the daunting complexities behind these events, including the details of genetic analysis, the perils of racial determinations, and the minutiae of patent law.New York Times, [Kahn] seems as much at home discussing epidemiology and drug marketing as he does the history of US race relations and the intricacies of patenting.... Magnificent., Kahn expertly weaves together the legal and ethical ramifications of continuing to pursue racialized drugs...no background in health sciences or genetics is necessary to understand this work., Jonathan Kahn is the undisputed Hercules Poirot of biomedicine. His unraveling of the nonsense, non-science and complicated illogic that allowed the vasodilator Bidil to be approved by the FDA exclusively for "black" patients is as compelling a read as any good mystery. This riveting book details what happens to scientific method when profit motive drives the marketing of a drug to the extent that its curative properties are touted as race-specific -- even when they're not. Genetic variation in humans has no correlation to the shifting historical meanings of race, yet pharmaceutical companies continue to force the square peg of social category into the round hole of scientific fact. Race in a Bottle is a brilliant deconstruction of the kinds of thought processes that make for bad policy, bad medicine and ultimately endanger our health as a species.
Dewey Edition
23
Grade From
College Graduate Student
Illustrated
Yes
Dewey Decimal
616.12906108996073
Table Of Content
Acknowledgments INTRODUCTION: Race and Medicine: Framing [Is] the Problem 1. ORGANIZING RACE: Paths Toward the Re-Biologization of Race in Modern Biomedical Research, Practice, and Product Development 2. THE BIRTH OF BIDIL: How a Drug Becomes "Ethnic" 3. STATISTICAL MISCHIEF AND RACIAL FRAMES FOR DRUG DEVELOPMENT AND MARKETING 4. CAPITALIZING [ON] RACE IN DRUG DEVELOPMENT 5. RACE-ING PATENTS/PATENTING RACE: An Emerging Political Geography of Intellectual Property in Biotechnology 6. NOT FADE AWAY: The Persistence of Race and the Politics of the "Meantime" in Pharmacogenomics 7. FROM DISPARITY TO DIFFERENCE: The Politics of Racial Medicine CONCLUSIONS AND RECOMMENDATIONS Notes Index
Synopsis
Approved by the FDA in 2005, BiDil was originally touted as a pathbreaking therapy to treat heart failure in black patients and help underserved populations. Upon closer examination, Jonathan Kahn reveals BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. Using BiDil as a case study, Kahn broadly examines the distinct politics informing the use of race in medicine and the very real health disparities caused by racism and social injustice that are being cast as a function of genetic difference. Kahn shows that, just as genetics is a complex field requiring sensitivity and expertise, so too is race, particularly in the field of biomedicine., At a ceremony announcing the completion of the first draft of the human genome in 2000, President Bill Clinton declared, "I believe one of the great truths to emerge from this triumphant expedition inside the human genome is that in genetic terms, all human beings, regardless of race, are more than 99.9 percent the same." Yet despite this declaration of unity, biomedical research has focused increasingly on mapping that.1 percent of difference, particularly as it relates to race. This trend is exemplified by the drug BiDil. Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was originally touted as a pathbreaking therapy to treat heart failure in black patients and help underserved populations. Upon closer examination, however, Jonathan Kahn reveals a far more complex story. At the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. Using BiDil as a central case study, Kahn broadly examines the legal and commercial imperatives driving the expanding role of race in biomedicine, even as scientific advances in genomics could render the issue irrelevant. He surveys the distinct politics informing the use of race in medicine and the very real health disparities caused by racism and social injustice that are now being cast as a mere function of genetic difference. Calling for a more reasoned approach to using race in biomedical research and practice, Kahn asks readers to recognize that, just as genetics is a complex field requiring sensitivity and expertise, so too is race, particularly in the field of biomedicine.
LC Classification Number
RM666.H7K34 2012
Descripción del artículo del vendedor
Información de vendedor profesional
Expert Trading Limited
John Boyer
9220 Rumsey Rd
Ste 101
21045-1956 Columbia, MD
United States
Certifico que todas mis actividades de venta cumplirán todas las leyes y reglamentos de la UE.
Registrado como vendedor profesional
Votos de vendedor (353.648)
- i***y (712)- Votos emitidos por el comprador.Últimos 6 mesesCompra verificada2 volumes of Pogo comic strips, new and in perfect condition. Price was good, but shipping cost ($30 for two books) seems like a lot for how long it took to get delivered (23 days from Illinois to Spain). Also, seller communication was not great. First two times I wrote, their response did not address question. Third response explained at length about the private courier service they use and how it should take 1-10 business days to deliver. Maybe they should consider a different courier service.
- o***l (313)- Votos emitidos por el comprador.Último añoCompra verificadaThe item was described to a Tee. Very good communication. Shipping was just a little slow. The box the set of books comes in was damaged (bent corners) due to packaging. Not a deal breaker because the grand kids will not store in that box; might be if it were to be given as a present. The three books in the box arrived in prefect shape. I WOULD purchase from greatbookprices1 again in the future. ThanksConstruction Site Board Books Set, Hardcover by Rinker, Sherri Duskey; Lichte... (#364394914625)
- r***_ (108)- Votos emitidos por el comprador.Mes pasadoCompra verificada*Same as the other review* Purchased two box sets from this seller with one being advertised as "like new" but was delivered as if it was actually new. Shipping time was a little slow, takes about 10 days to ship out and it takes a while to get through the system. But the packing was great and I'm still overall happy with my purchase.